top of page

State of Possible: IMMEDIATE Therapeutics is developing a medicine for the critical time before heart attack sufferers make it to the hospital

  • Mar 26
  • 1 min read

CEO Atul Deshpande describes how every minute counts after a heart attack yet patients typically do not receive and medicine until they reach the hospital. He explains what IMMEDIATE's solution is, which is phase 3 ready and has a SPA from FDA.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page